In addition, miR-155-5p inhibition could promote the transition of bone marrow-derived MSCs into gastric cancer tissue-derived MSC-like cells (GC-MSCs) via NF-κB p65 activation (73). The gene discussed is NFKB1; the disease is gastric cancer.